{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T01:55:00Z","timestamp":1780365300945,"version":"3.54.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Coinfections and reactivation of persistent or latent viral infections such as herpesviruses (HHV) and\/or measles virus (MeV) have been reported among COVID-19 patients. However, there is limited information regarding cancer patients who experienced severe acute respiratory syndrome corona virus-2 (SARS-CoV-2). The primary purpose of this study was to investigate the interplay between SARS-CoV-2, HHV and MeV in cancer patients, aiming to provide insights into the pathophysiology of these infections and to enhance the patients\u2019 health outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A prospective observational study was conducted on 4 groups (<jats:italic>n<\/jats:italic>\u2009=\u2009147): newly diagnosed cancer patients infected with SARS-CoV-2 (<jats:italic>n<\/jats:italic>\u2009=\u200937), newly diagnosed cancer patients non-infected with SARS-CoV-2 (<jats:italic>n<\/jats:italic>\u2009=\u200913), apparently normal individuals infected with SARS-CoV-2 (<jats:italic>n<\/jats:italic>\u2009=\u200982) and finally a normal control group (<jats:italic>n<\/jats:italic>\u2009=\u200915). All samples were tested for SARS-CoV-2 infection using the real-rime quantitative reverse transcription polymerase chain reaction (qRT-PCR). Antibody responses were analyzed using indirect enzyme-linked immunosorbent assay (ELISA), and antibody levels were compared between patients and controls. Potential re-activation was investigated using fourfold (i.e. 400%) rise model criterion.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In all positive cases of SARS-CoV-2, recent infections or re-infection of herpes simplex viruses 1 and 2 (HSV1\/2 or HHV1-2) were found to be significantly increased approximately three-fold higher in COVID-19 patients (<jats:italic>p<\/jats:italic>\u2009=\u20090.007) identified via pooled HSV1\/2 IgM levels in plasma. Furthermore, reactivation of HSV1\/2 was 29.7% in cancer\/COVID-19 patients (<jats:italic>n<\/jats:italic>\u2009=\u200937) versus 0.0% of normal\/COVID-19 group (<jats:italic>n<\/jats:italic>\u2009=\u200922) (<jats:italic>p<\/jats:italic>\u2009=\u20090.008). Likewise, Epstein-Barr Nuclear Antigen-1 (EBNA-1) IgG levels showed a\u2009\u2265\u2009fourfold increase in 20% (<jats:italic>p<\/jats:italic>\u2009=\u20090.034) of cancer patients (<jats:italic>n<\/jats:italic>\u2009=\u200950) versus 4.9% of controls (<jats:italic>n<\/jats:italic>\u2009=\u200941) for reactivation of Epstein-Barr virus (EBV or HHV-4). Obviously, MeV IgG levels increased up to 78.0% in cancer patients (<jats:italic>n<\/jats:italic>\u2009=\u200950) versus 17.5% in non-cancerous group (<jats:italic>n<\/jats:italic>\u2009=\u200940, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Reactivation of MeV in cancer and COVID-19 patients was 43.2% versus 30.8% cancer non-COVID-19 group, 3.3% normal COVID-19, and 0.0% in healthy volunteers (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Cancer patients infected with SARS-CoV-2 were at increased risk of HHV and MeV co-infection and reactivation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s43046-025-00275-1","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T13:25:02Z","timestamp":1744377902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Co-infections and Reactivation of some Herpesviruses (HHV) and Measles Virus (MeV) in Egyptian Cancer Patients infected with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)"],"prefix":"10.1186","volume":"37","author":[{"given":"Ahmed M.","family":"Mayla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed S.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel-Rahman N.","family":"Zekri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora A.","family":"Gouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai M.","family":"Lotfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed G.","family":"Seadawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Abdel-Salam","family":"Elgohary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab F.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"275_CR1","doi-asserted-by":"crossref","unstructured":"Zhu, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u201333.","DOI":"10.1056\/NEJMoa2001017"},{"key":"275_CR2","unstructured":"Levinson W, Chin-Hong P, Joyce EA, Nussbaum J, Schwartz B. Respiratory Viruses. Review of Medical Microbiology & Immunology: A Guide to Clinical Infectious Diseases, 17e. New York, NY: McGraw-Hill Education; 2022."},{"key":"275_CR3","unstructured":"Current ICTV Taxonomy Release. 2024. Available from: https:\/\/ictv.global\/taxonomy."},{"issue":"4","key":"275_CR4","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.3390\/jcm9041225","volume":"9","author":"YA Helmy","year":"2020","unstructured":"Helmy YA, Fawzy M, Elaswad A, Sobieh A, Kenney SP, Shehata AA. The COVID-19 pandemic: a comprehensive review of taxonomy, genetics, epidemiology, diagnosis, treatment, and control. J Clin Med. 2020;9(4):1225.","journal-title":"J Clin Med"},{"key":"275_CR5","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","volume":"109","author":"HA Rothan","year":"2020","unstructured":"Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.","journal-title":"J Autoimmun"},{"key":"275_CR6","unstructured":"Chou SH-Y, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V, et al. Global incidence of neurological manifestations among patients hospitalized with COVID-19\u2014a report for the GCS-NeuroCOVID consortium and the ENERGY consortium. JAMA Network Open. 2021;4(5):e2112131-e."},{"key":"275_CR7","doi-asserted-by":"publisher","unstructured":"Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol. 2020;34(5):e212\u20133. https:\/\/doi.org\/10.1111\/jdv.16387.\u00a0","DOI":"10.1111\/jdv.16387"},{"issue":"3","key":"275_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/diseases4030026","volume":"4","author":"YX Lim","year":"2016","unstructured":"Lim YX, Ng YL, Tam JP, Liu DX. Human coronaviruses: a review of virus\u2013host interactions. Diseases. 2016;4(3):26.","journal-title":"Diseases"},{"key":"275_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-021-02058-6","volume":"19","author":"M Treskova-Schwarzbach","year":"2021","unstructured":"Treskova-Schwarzbach M, Haas L, Reda S, Pilic A, Borodova A, Karimi K, et al. Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence. BMC Med. 2021;19:1\u201326.","journal-title":"BMC Med"},{"key":"275_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00907-0","volume":"13","author":"Y Meng","year":"2020","unstructured":"Meng Y, Lu W, Guo E, Liu J, Yang B, Wu P, et al. Cancer history is an independent risk factor for mortality in hospitalized COVID-19 patients: a propensity score-matched analysis. J Hematol Oncol. 2020;13:1\u201311.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"275_CR11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2217\/fvl.11.21","volume":"6","author":"CM Traylen","year":"2011","unstructured":"Traylen CM, Patel HR, Fondaw W, Mahatme S, Williams JF, Walker LR, et al. Virus reactivation: a panoramic view in human infections. Futur Virol. 2011;6(4):451\u201363.","journal-title":"Futur Virol"},{"issue":"1","key":"275_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.chom.2010.06.014","volume":"8","author":"SH Speck","year":"2010","unstructured":"Speck SH, Ganem D. Viral latency and its regulation: lessons from the \u03b3-herpesviruses. Cell Host Microbe. 2010;8(1):100\u201315.","journal-title":"Cell Host Microbe"},{"key":"275_CR13","doi-asserted-by":"publisher","unstructured":"Grinde B. Herpesviruses: latency and reactivation-viral strategies and host response. J Oral Microbiol. 2013; 5. Epub 2013\/10\/30. https:\/\/doi.org\/10.3402\/jom. v5i0. 22766. PubMed PMID: 24167660; 2013.","DOI":"10.3402\/jom"},{"key":"275_CR14","unstructured":"Ryan KJ. Persistent Viral Infections of the Central Nervous System. Sherris & Ryan\u2019s Medical Microbiology, 8th Edition. New York, NY: McGraw-Hill Education; 2022. https:\/\/accessmedicine.mhmedical.com\/content.aspx?bookid=3107\u00a7sectionid=260925500."},{"issue":"9","key":"275_CR15","first-page":"2417","volume":"164","author":"PJ Walker","year":"2019","unstructured":"Walker PJ, Siddell SG, Lefkowitz EJ, Mushegian AR, Dempsey DM, Dutilh BE, et al. Changes to virus taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2019). Adv Virol. 2019;164(9):2417\u201329.","journal-title":"Adv Virol"},{"key":"275_CR16","doi-asserted-by":"publisher","unstructured":"Fuest KE, Erber J, Berg-Johnson W, Heim M, Hoffmann D, Kapfer B, et al. Risk factors for Herpes simplex virus (HSV) and Cytomegalovirus (CMV) infections in critically-ill COVID-19 patients. Multidisciplinary Respiratory Med. 2022;17(1). Multidiscip Respir Med. 2022;17(1):815. https:\/\/doi.org\/10.4081\/mrm.2022.815.\u00a0","DOI":"10.4081\/mrm.2022.815"},{"issue":"3","key":"275_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1002\/jmv.27421","volume":"94","author":"Y Yamamoto","year":"2022","unstructured":"Yamamoto Y, Shiroyama T, Hirata H, Kuge T, Matsumoto K, Yoneda M, et al. Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID-19. J Med Virol. 2022;94(3):1067\u201373.","journal-title":"J Med Virol"},{"key":"275_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06638-y","volume":"21","author":"Y Xie","year":"2021","unstructured":"Xie Y, Cao S, Dong H, Lv H, Teng X, Zhang J, et al. Clinical characteristics and outcomes of critically ill patients with acute COVID-19 with Epstein-Barr virus reactivation. BMC Infect Dis. 2021;21:1\u20138.","journal-title":"BMC Infect Dis"},{"key":"275_CR19","doi-asserted-by":"publisher","unstructured":"Grandolfo M, Romita P, Bonamonte D, Cazzato G, Hansel K, Stingeni L, Conforti C, Giuffrida R, Foti C. Drug reaction with eosinophilia and systemic symptoms syndrome to hydroxychloroquine, an old drug in the spotlight in the COVID-19 era. Dermatol Ther. 2020;33(4):e13499. https:\/\/doi.org\/10.1111\/dth.13499.\u00a0","DOI":"10.1111\/dth.13499"},{"key":"275_CR20","doi-asserted-by":"crossref","unstructured":"Le Balc\u2019h P, Pinceaux K, Pronier C, Seguin P, Tadi\u00e9 J-M, Reizine F. Herpes simplex virus and cytomegalovirus reactivations among severe COVID-19 patients. Critical Care. 2020;24:1\u20133.","DOI":"10.1186\/s13054-020-03252-3"},{"issue":"4","key":"275_CR21","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.4103\/ijo.IJO_2838_21","volume":"70","author":"N Das","year":"2022","unstructured":"Das N, Das J, Pal D. Stromal and endothelial herpes simplex virus keratitis reactivation in the convalescent period of COVID-19\u2013A case report. Indian J Ophthalmol. 2022;70(4):1410\u20132.","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"275_CR22","doi-asserted-by":"publisher","first-page":"5313832","DOI":"10.1155\/2021\/5313832","volume":"2021","author":"P Malekifar","year":"2021","unstructured":"Malekifar P, Pakzad R, Shahbahrami R, Zandi M, Jafarpour A, Rezayat SA, et al. Viral coinfection among COVID-19 patient groups: an update systematic review and meta-analysis. Biomed Res Int. 2021;2021(1):5313832.","journal-title":"Biomed Res Int"},{"key":"275_CR23","doi-asserted-by":"publisher","unstructured":"Mohamed WS, Aldabbagh HA, Aldughmani HA, Abdullah ZF, Kassem SA, Abdel-Almoniem IA, Ibrahim MF. Prevalence of Human Herpesviruses (HHV1-7), and its Clinical Significance in Middle Eastern Pediatric Leukemia Patients Using 2 Independent PCR Assays. J Appl Microb Res. 2022;5(2):30\u20138. https:\/\/doi.org\/10.20944\/preprints202208.0520.v1.","DOI":"10.20944\/preprints202208.0520.v1"},{"issue":"9","key":"275_CR24","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/cid\/cix120","volume":"64","author":"DS Ong","year":"2017","unstructured":"Ong DS, Bonten MJ, Spitoni C, Verduyn Lunel FM, Frencken JF, Horn J, et al. Epidemiology of multiple herpes viremia in previously immunocompetent patients with septic shock. Clin Infect Dis. 2017;64(9):1204\u201310.","journal-title":"Clin Infect Dis"},{"key":"275_CR25","doi-asserted-by":"publisher","unstructured":"Shanshal M, Ahmed HS. COVID-19 and Herpes Simplex Virus Infection: A Cross-Sectional Study. Cureus. 2021;13(9):e18022. https:\/\/doi.org\/10.7759\/cureus.18022.\u00a0","DOI":"10.7759\/cureus.18022"},{"key":"275_CR26","doi-asserted-by":"publisher","unstructured":"K\u00e4mmerer T, Walch J, Flaig M, French LE. COVID-19-associated herpetic gingivostomatitis. Clin Exp Dermatol. 2021;46(1):174\u20136. https:\/\/doi.org\/10.1111\/ced.14402.\u00a0","DOI":"10.1111\/ced.14402"},{"issue":"3","key":"275_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00277-021-04746-y","volume":"101","author":"L Henze","year":"2022","unstructured":"Henze L, Buhl C, Sandherr M, Cornely OA, Heinz WJ, Khodamoradi Y, et al. Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus. Ann Hematol. 2022;101(3):491\u2013511.","journal-title":"Ann Hematol"},{"issue":"8","key":"275_CR28","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/S2665-9913(20)30173-9","volume":"2","author":"G Guaraldi","year":"2020","unstructured":"Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M, et al. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020;2(8):e474\u201384.","journal-title":"Lancet Rheumatol"},{"issue":"3","key":"275_CR29","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.idnow.2021.01.005","volume":"51","author":"A Simonnet","year":"2021","unstructured":"Simonnet A, Engelmann I, Moreau A-S, Garcia B, Six S, El Kalioubie A, et al. High incidence of Epstein-Barr virus, cytomegalovirus, and human-herpes virus-6 reactivations in critically ill patients with COVID-19. Infect Dis Now. 2021;51(3):296\u20139.","journal-title":"Infect Dis Now"},{"issue":"1","key":"275_CR30","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.1038\/s41598-021-90351-y","volume":"11","author":"T Chen","year":"2021","unstructured":"Chen T, Song J, Liu H, Zheng H, Chen C. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep. 2021;11(1):10902.","journal-title":"Sci Rep"},{"issue":"6","key":"275_CR31","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3390\/pathogens10060763","volume":"10","author":"JE Gold","year":"2021","unstructured":"Gold JE, Okyay RA, Licht WE, Hurley DJ. Investigation of long COVID prevalence and its relationship to Epstein-Barr virus reactivation. Pathogens. 2021;10(6):763.","journal-title":"Pathogens"},{"key":"275_CR32","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00277-020-04098-z","volume":"99","author":"L Roncati","year":"2020","unstructured":"Roncati L, Lusenti B, Nasillo V, Manenti A. Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease. Ann Hematol. 2020;99:1945\u20136.","journal-title":"Ann Hematol"},{"key":"275_CR33","doi-asserted-by":"publisher","unstructured":"Dabbagh A, Laws RL, Steulet C, Dumolard L, Mulders MN, Kretsinger K, Alexander JP, Rota PA, Goodson JL. Progress Toward Regional Measles Elimination - Worldwide, 2000-2017. MMWR Morb Mortal Wkly Rep. 2018;67(47):1323\u20139. https:\/\/doi.org\/10.15585\/mmwr.mm6747a6.\u00a0","DOI":"10.15585\/mmwr.mm6747a6"},{"issue":"3","key":"275_CR34","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41591-021-01237-5","volume":"27","author":"DN Durrheim","year":"2021","unstructured":"Durrheim DN, Andrus JK, Tabassum S, Bashour H, Githanga D, Pfaff G. A dangerous measles future looms beyond the COVID-19 pandemic. Nat Med. 2021;27(3):360\u20131.","journal-title":"Nat Med"},{"issue":"1","key":"275_CR35","doi-asserted-by":"publisher","first-page":"e1218","DOI":"10.1097\/IPC.0000000000001218","volume":"31","author":"H Moradi","year":"2023","unstructured":"Moradi H. COVID-19 and Measles. Infect Dis Clin Pract. 2023;31(1):e1218.","journal-title":"Infect Dis Clin Pract"},{"key":"275_CR36","doi-asserted-by":"crossref","unstructured":"Lebo EJ, Kruszon-Moran DM, Marin M, Bellini WJ, Schmid S, Bialek SR, et al., editors. Seroprevalence of measles, mumps, rubella and varicella antibodies in the United States population, 2009\u20132010. Open forum infectious diseases; 2015: Oxford University Press.","DOI":"10.1093\/ofid\/ofv006"},{"key":"275_CR37","unstructured":"Ryan KJ. Respiratory Viruses. Sherris & Ryan\u2019s Medical Microbiology, 8th Edition. New York, NY: McGraw-Hill Education; 2022. https:\/\/accessmedicine.mhmedical.com\/content.aspx?bookid=3107&sectionid=260923446."},{"issue":"1","key":"275_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12879-023-08117-y","volume":"23","author":"JYH Kim","year":"2023","unstructured":"Kim JYH, Ragusa M, Tortosa F, Torres A, Gresh L, Mendez-Rico JA, et al. Viral reactivations and co-infections in COVID-19 patients: a systematic review. BMC Infect Dis. 2023;23(1):259.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"275_CR39","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s40001-023-01238-9","volume":"28","author":"A Shafiee","year":"2023","unstructured":"Shafiee A, Amini MJ, Arabzadeh Bahri R, Jafarabady K, Salehi SA, Hajishah H, et al. Herpesviruses reactivation following COVID-19 vaccination: a systematic review and meta-analysis. Eur J Med Res. 2023;28(1):278.","journal-title":"Eur J Med Res"},{"key":"275_CR40","doi-asserted-by":"publisher","first-page":"105623","DOI":"10.1016\/j.jcv.2023.105623","volume":"170","author":"EW Coan","year":"2024","unstructured":"Coan EW, Tuon FF. Laboratory diagnosis of measles infection using molecular and serology during 2019\u20132020 outbreak in Brazil. J Clin Virol. 2024;170:105623.","journal-title":"J Clin Virol"},{"issue":"10","key":"275_CR41","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.jiph.2023.08.002","volume":"16","author":"YC Kim","year":"2023","unstructured":"Kim YC, Nam H, Choi JY, Shin E-C, Choi YH. The third dose of measles-containing vaccine induces robust immune responses against measles in young seronegative healthcare workers who had previous two-dose measles vaccination. J Infect Public Health. 2023;16(10):1643\u20139.","journal-title":"J Infect Public Health"},{"issue":"3","key":"275_CR42","doi-asserted-by":"publisher","first-page":"306","DOI":"10.21608\/aeji.2021.72615.1144","volume":"11","author":"A Al Balakosy","year":"2021","unstructured":"Al Balakosy A, Alfishawy M, Elnabawy O, Hassan A, Shamkh M, Mahmoud M, et al. Measles IgG Antibodies: Is There a Protective Role in COVID 19 Pandemic? Afro-Egyptian J Infect Endemic Dis. 2021;11(3):306\u201313.","journal-title":"Afro-Egyptian J Infect Endemic Dis"},{"issue":"1","key":"275_CR43","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1080\/16078454.2021.1992117","volume":"26","author":"EZ Kandeel","year":"2021","unstructured":"Kandeel EZ, Refaat L, Abdel-Fatah R, Samra M, Bayoumi A, Abdellateif MS, et al. Could COVID-19 induce remission of acute leukemia? Hematology. 2021;26(1):870\u20133.","journal-title":"Hematology"},{"issue":"6","key":"275_CR44","doi-asserted-by":"publisher","first-page":"352","DOI":"10.14740\/jocmr4200","volume":"12","author":"S Adapa","year":"2020","unstructured":"Adapa S, Chenna A, Balla M, Merugu GP, Koduri NM, Daggubati SR, et al. COVID-19 pandemic causing acute kidney injury and impact on patients with chronic kidney disease and renal transplantation. J Clin Med Res. 2020;12(6):352.","journal-title":"J Clin Med Res"},{"issue":"2","key":"275_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jpha.2020.02.010","volume":"10","author":"M Shen","year":"2020","unstructured":"Shen M, Zhou Y, Ye J, Al-Maskri AAA, Kang Y, Zeng S, et al. Recent advances and perspectives of nucleic acid detection for coronavirus. J Pharm Anal. 2020;10(2):97\u2013101.","journal-title":"J Pharm Anal"},{"key":"275_CR46","first-page":"1617","volume":"162","author":"JY Noh","year":"2017","unstructured":"Noh JY, Yoon S-W, Kim D-J, Lee M-S, Kim J-H, Na W, et al. Simultaneous detection of severe acute respiratory syndrome, Middle East respiratory syndrome, and related bat coronaviruses by real-time reverse transcription PCR. Adv Virol. 2017;162:1617\u201323.","journal-title":"Adv Virol"},{"key":"275_CR47","doi-asserted-by":"crossref","unstructured":"Wan Z, Zhang Yn, He Z, Liu J, Lan K, Hu Y, et al. A melting curve-based multiplex RT-qPCR assay for simultaneous detection of four human coronaviruses. Int J Mol Sci. 2016;17(11):1880.","DOI":"10.3390\/ijms17111880"},{"issue":"1","key":"275_CR48","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12879-022-07095-x","volume":"22","author":"H Parmar","year":"2022","unstructured":"Parmar H, Montovano M, Banada P, Pentakota SR, Shiau S, Ma Z, et al. RT-PCR negative COVID-19. BMC Infect Dis. 2022;22(1):149.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"275_CR49","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/14737159.2020.1757437","volume":"20","author":"A Tahamtan","year":"2020","unstructured":"Tahamtan A, Ardebili A. Real-time RT-PCR in COVID-19 detection: issues affecting the results. Expert Rev Mol Diagn. 2020;20(5):453\u20134.","journal-title":"Expert Rev Mol Diagn"},{"issue":"10","key":"275_CR50","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.3390\/diagnostics11101760","volume":"11","author":"W-Y Hsieh","year":"2021","unstructured":"Hsieh W-Y, Lin C-H, Lin T-C, Lin C-H, Chang H-F, Tsai C-H, et al. Development and efficacy of lateral flow point-of-care testing devices for rapid and mass COVID-19 diagnosis by the detections of SARS-CoV-2 antigen and anti-SARS-CoV-2 antibodies. Diagnostics. 2021;11(10):1760.","journal-title":"Diagnostics"},{"issue":"3","key":"275_CR51","first-page":"210","volume":"69","author":"A-M Davitoiu","year":"2020","unstructured":"Davitoiu A-M, Chindris S, Iancu MS, Tincu I, Spatariu LE, Plesca DA. Paraclinical management of SARS-COV-2 infection in paediatric patient. Romanian J Pediatr. 2020;69(3):210.","journal-title":"Romanian J Pediatr"},{"key":"275_CR52","doi-asserted-by":"crossref","unstructured":"Casti\u00f1eiras ACP, Sales AC, Picone CdM, Diogo CL, Rossi \u00c1D, Galliez RM, et al. The decline of measles antibody titers in previously vaccinated adults: a cross-sectional analysis. Revista do Instituto de Medicina Tropical de S\u00e3o Paulo. 2024;66:e4.","DOI":"10.1590\/s1678-9946202466004"},{"key":"275_CR53","unstructured":"UNICEF. Routine immunization United Nations International Children\u2019s Emergency Fund 2024 [Available from: https:\/\/www.unicef.org\/egypt\/vaccines."},{"key":"275_CR54","doi-asserted-by":"crossref","unstructured":"El Sayed N, Kandeel N, Barakat I, Moussa I, Alexander J, Naouri B, et al. Progress toward measles and rubella elimination in Egypt. J Infect Dis. 2011;204(suppl_1):S318-S24.","DOI":"10.1093\/infdis\/jir123"},{"issue":"10","key":"275_CR55","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3390\/v8100282","volume":"8","author":"DE Griffin","year":"2016","unstructured":"Griffin DE. The immune response in measles: virus control, clearance and protective immunity. Viruses. 2016;8(10):282.","journal-title":"Viruses"},{"key":"275_CR56","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fmolb.2020.00120","volume":"7","author":"KR Sidiq","year":"2020","unstructured":"Sidiq KR, Sabir DK, Ali SM, Kodzius R. Does early childhood vaccination protect against COVID-19? Front Mol Biosci. 2020;7:120.","journal-title":"Front Mol Biosci"},{"key":"275_CR57","doi-asserted-by":"crossref","unstructured":"Brodin P. Why is COVID\u201019 so mild in children? : Wiley Online Library; 2020. p. 1082\u20133.","DOI":"10.1111\/apa.15271"},{"key":"275_CR58","doi-asserted-by":"crossref","unstructured":"Marquis SR, Logue JK, Chu HY, Loeffelholz T, Quinn Z, Liu C, et al. Seroprevalence of measles and mumps antibodies among individuals with cancer. JAMA Network Open. 2021;4(7):e2118508-e.","DOI":"10.1001\/jamanetworkopen.2021.18508"},{"key":"275_CR59","doi-asserted-by":"crossref","unstructured":"Saad ME, Elsalamony RA. Measles vaccines may provide partial protection against COVID-19. Egypt J Cancer Biomed Res. 2020;4(Special Issue):15\u20139.","DOI":"10.21608\/jcbr.2020.26765.1024"},{"issue":"1","key":"275_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00005-023-00680-1","volume":"71","author":"A Salamony","year":"2023","unstructured":"Salamony A, Shamikh Y, Amer K, Elnagdy T, Elnakib M, Yehia AA, et al. Are Measles-Mumps-Rubella (MMR) Antibodies Friends or Foes for Covid-19 Disease? Arch Immunol Ther Exp. 2023;71(1):15.","journal-title":"Arch Immunol Ther Exp"},{"issue":"5","key":"275_CR61","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2471\/BLT.19.237149","volume":"98","author":"C James","year":"2020","unstructured":"James C, Harfouche M, Welton NJ, Turner KM, Abu-Raddad LJ, Gottlieb SL, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020;98(5):315.","journal-title":"Bull World Health Organ"},{"issue":"9","key":"275_CR62","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1164\/rccm.200609-1322OC","volume":"175","author":"C-E Luyt","year":"2007","unstructured":"Luyt C-E, Combes A, Deback C, Aubriot-Lorton M-H, Nieszkowska A, Trouillet J-L, et al. Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation. Am J Respir Crit Care Med. 2007;175(9):935\u201342.","journal-title":"Am J Respir Crit Care Med"},{"key":"275_CR63","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1007\/s00134-008-1231-4","volume":"34","author":"CF Linssen","year":"2008","unstructured":"Linssen CF, Jacobs JA, Stelma FF, van Mook WN, Terporten P, Vink C, et al. Herpes simplex virus load in bronchoalveolar lavage fluid is related to poor outcome in critically ill patients. Intensive Care Med. 2008;34:2202\u20139.","journal-title":"Intensive Care Med"},{"issue":"1","key":"275_CR64","first-page":"1","volume":"2","author":"G Simonia","year":"2024","unstructured":"Simonia G, Sutlu T, Okrostsvaridze N, Tavartkiladze G. Mechanisms of Sars-Cov-2 Induced Endothelial Damage, Immunosuppression, and Dyslipidemia: Implications for Sudden Death and Cancer Risks and the Therapeutic Role of a New Antiviral, Proapoptotic and Immunomodulating Remedy Soulager. J Cancer Res. 2024;2(1):1\u201319.","journal-title":"J Cancer Res"},{"key":"275_CR65","doi-asserted-by":"publisher","unstructured":"Zhu A, Zhou L, Chen Z, Liu D, Feng H, Cai B, Chen X, Zhao J, Zhao J, Chen J, Li M, He J. Single-cell analysis reveals T cell dysfunction driven by macrophages and differential expression of transposable elements in severe COVID-19 patients. Heliyon. 2024;10(19):e38688. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e38688.\u00a0","DOI":"10.1016\/j.heliyon.2024.e38688"},{"key":"275_CR66","doi-asserted-by":"crossref","unstructured":"M\u00fcnz C, editor Immune control of human \u03b3-herpes infections. Seminars in Arthritis and Rheumatism; 2024: Elsevier.","DOI":"10.1016\/j.semarthrit.2023.152320"},{"key":"275_CR67","doi-asserted-by":"publisher","unstructured":"Auerbach A, Schmieg JJ, Klassen M, Nelson A, Aguilera NS. HIV, measles, and syphilis: histopathologic characteristics of lymphatic system involvement of three reemerging infectious diseases. Histopathology. 2024. https:\/\/doi.org\/10.1111\/his.15408. Epub ahead of print.\u00a0","DOI":"10.1111\/his.15408"},{"key":"275_CR68","doi-asserted-by":"publisher","unstructured":"Contreras A, S\u00e1nchez SA, Rodr\u00edguez-Medina C, Botero JE. The role and impact of viruses on cancer development. Periodontol 2000. 2024;96(1):170\u201384. https:\/\/doi.org\/10.1111\/prd.12566.\u00a0","DOI":"10.1111\/prd.12566"},{"key":"275_CR69","doi-asserted-by":"publisher","unstructured":"Baral B, Saini V, Kandpal M, Kundu P, Dixit AK, Parmar HS, Meena AK, Trivedi P, Jha HC. The interplay of co-infections in shaping COVID-19 severity: Expanding the scope beyond SARS-CoV-2. J Infect Public Health. 2024;17(8):102486. https:\/\/doi.org\/10.1016\/j.jiph.2024.102486.\u00a0","DOI":"10.1016\/j.jiph.2024.102486"},{"issue":"4","key":"275_CR70","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/s41556-024-01388-w","volume":"26","author":"T Duan","year":"2024","unstructured":"Duan T, Xing C, Chu J, Deng X, Du Y, Liu X, et al. ACE2-dependent and-independent SARS-CoV-2 entries dictate viral replication and inflammatory response during infection. Nat Cell Biol. 2024;26(4):628\u201344.","journal-title":"Nat Cell Biol"},{"key":"275_CR71","doi-asserted-by":"publisher","unstructured":"Rotstein C. Viral infections in cancer patients. In: Higby DJ, editor. The Cancer Patient and Supportive Care: Medical, Surgical, and Human Issues. Boston, MA: Springer US; 1985. p. 57\u201397. https:\/\/doi.org\/10.1007\/978-1-4613-2567-3_3.","DOI":"10.1007\/978-1-4613-2567-3_3"},{"issue":"2","key":"275_CR72","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/v16020183","volume":"16","author":"A Roy","year":"2024","unstructured":"Roy A, Ghosh A. Epigenetic Restriction Factors (eRFs) in Virus Infection. Viruses. 2024;16(2):183.","journal-title":"Viruses"},{"issue":"3","key":"275_CR73","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/biotech12030054","volume":"12","author":"MG Aruta","year":"2023","unstructured":"Aruta MG, Lari E, De Simone D, Semplici B, Semplici C, Dale H, et al. Characterization of Enzyme-Linked Immunosorbent Assay (ELISA) for Quantification of Antibodies against Salmonella Typhimurium and Salmonella Enteritidis O-Antigens in Human Sera. Biotech. 2023;12(3):54.","journal-title":"Biotech"},{"issue":"7","key":"275_CR74","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/rheumatology\/kead552","volume":"63","author":"H K\u00e4llmark","year":"2024","unstructured":"K\u00e4llmark H, Bergstr\u00f6m T, Nagel J, Gullstrand B, Einarsson JT, Bengtsson AA, et al. Serologic immunogenicity and safety of Herpes Zoster subunit vaccine in patients with Rheumatoid Arthritis receiving Janus Kinase inhibitors. Rheumatology. 2024;63(7):2024\u201333.","journal-title":"Rheumatology"},{"issue":"4","key":"275_CR75","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/(SICI)1099-1654(199910\/12)9:4<245::AID-RMV253>3.0.CO;2-I","volume":"9","author":"JB Black","year":"1999","unstructured":"Black JB, Pellett PE. Human herpesvirus 7. Rev Med Virol. 1999;9(4):245\u201362.","journal-title":"Rev Med Virol"},{"key":"275_CR76","unstructured":"NJ.gov. New Jersey Department of Health, Vaccine Preventable Disease Program, Measles laboratory testing faqs: official site of the state of New Jersey; 2024 [Available from: https:\/\/www.nj.gov\/health\/cd\/documents\/topics\/measles\/measles_lab_testing_faq.pdf."}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00275-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43046-025-00275-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-025-00275-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T17:06:03Z","timestamp":1744391163000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-025-00275-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["275"],"URL":"https:\/\/doi.org\/10.1186\/s43046-025-00275-1","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The institutional review board (IRP) ethical committee approved this study, according to the Helsinki and Belmont principles, to be conducted at National Cancer Institute, Cairo University (IORG0003381) IRP No. IRB00004025. The patient\u2019s data presented anonymously with protection of privacy and confidentiality. Informed written consent to participate in the study was provided by all participants for prospective observational studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}